Keyphrases
Erythropoietin
100%
Erythropoietin Receptor
65%
Acetylcholine Receptor (AChR)
38%
Synthetic Peptides
19%
Erythropoietin Therapy
19%
RhEPO
18%
Bone Loss
17%
Madagascar
14%
Cytoplasmic Domain
11%
Nitrogenous Macrolide
11%
Acetylcholine Receptor Subunit
11%
Multiple Myeloma
10%
Phosphorylation
10%
Erythropoiesis
10%
Endoplasmic Reticulum
9%
Anemia
9%
1D NMR
9%
Binding Site
9%
Osteoclast
8%
Acetylcholine Receptor Antibody
8%
K562 Leukemia Cells
8%
α2δ Subunit
8%
Phosphorylation Sites
8%
Immune Response
8%
Anti-peptide Antibody
8%
Geldanamycin
7%
T Cells
7%
2D NMR Spectra
7%
Protein Kinase
7%
Erythroid
6%
Cell Proliferation
6%
Myeloma
6%
Apoptosis
6%
Epidermal Growth Factor Receptor
6%
Erythropoiesis-stimulating Agents
6%
Receptor Signaling
6%
Monoclonal Antibody
6%
Experimental Autoimmune Myasthenia Gravis
6%
Ligand Binding
6%
Intracellular Degradation
5%
CAMP-dependent Protein Kinase
5%
Oncology Patients
5%
Bioactive
5%
Toxin Binding
5%
Blood Glucose
5%
Myasthenia Gravis
5%
Protein Tyrosine Phosphatase 1B (PTP1B)
5%
Bone Remodeling
5%
Cell Surface
5%
Osteoclastogenesis
5%
Immunology and Microbiology
Erythropoietin
76%
Erythropoietin Receptor
35%
Peptides
23%
Epoetin Beta
16%
Osteolysis
12%
Binding Site
11%
Multiple Myeloma
10%
Immune Response
9%
B Cell
9%
T Cell
7%
Precursor
7%
Ligand Binding
6%
Cell Surface
6%
Experimental Autoimmune Myasthenia Gravis
6%
Bone Remodeling
5%
Amino Acid
5%
Osteoclast
5%
Dendritic Cell
5%
Cysteine
5%
Antibody Titer
5%
Myasthenia gravis
5%
Endoplasmic reticulum
5%
Biochemistry, Genetics and Molecular Biology
Erythropoietin
67%
Erythropoietin Receptor
48%
Acetylcholine Receptor
19%
Binding Site
9%
Osteolysis
9%
Osteoclast
8%
Geldanamycin
7%
Maturation
7%
Cyclic Adenosine Monophosphate
7%
Precursor
7%
Epidermal Growth Factor Receptor
6%
Ligand Binding
6%
Protein Kinase C
6%
Tyrosine
5%
Macrophage
5%
Erythropoiesis
5%
Protein Tyrosine Phosphatase
5%
Glucose Blood Level
5%
Signal Transduction
5%
Protein Kinases
5%
Amino Acids
5%
